Insider transactions

EDGAR

CHAMPIONS ONCOLOGY, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–6 of 6

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-05 Filed 2026-11-09SIDRANSKY DAVID Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option to purchase Common Stock — underlying Common Stock (31,216) — exercise price 4.76
Acquired (A)31,2164.76
148,588.16

Derived: shares × price per share. Exact value 148588.16.

31,216Direct (D) No
F1
  • F1 The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2026, February 5, 2027, May 5, 2027 and August 5, 2027, respectively.
Open filing 0001628280-26-072283 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-09TOBIN SCOTT R Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option to purchase Common Stock — underlying Common Stock (37,460) — exercise price 4.76
Acquired (A)37,4604.76
178,309.6

Derived: shares × price per share. Exact value 178309.60.

37,460Direct (D) No
F1
  • F1 The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2026, February 5, 2027, May 5, 2027 and August 5, 2027, respectively.
Open filing 0001628280-26-072248 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-09ACKERMAN JOEL Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option to purchase Common Stock — underlying Common Stock (31,216) — exercise price 4.76
Acquired (A)31,2164.76
148,588.16

Derived: shares × price per share. Exact value 148588.16.

31,216Direct (D) No
F1
  • F1 The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2026, February 5, 2027, May 5, 2027 and August 5, 2027, respectively.
Open filing 0001628280-26-072233 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-09Mendelson Daniel Newman Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option to purchase Common Stock — underlying Common Stock (20,291) — exercise price 4.76
Acquired (A)20,2914.76
96,585.16

Derived: shares × price per share. Exact value 96585.16.

20,291Direct (D) No
F1
  • F1 The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2026, February 5, 2027, May 5, 2027 and August 5, 2027, respectively.
Open filing 0001628280-26-072275 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-16ACKERMAN JOEL Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)69,7941.60
111,670.4

Derived: shares × price per share. Exact value 111670.40.

1,126,333Direct (D) No— Open filing 0001628280-26-066091 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-16ACKERMAN JOEL Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option to purchase Common Stock — underlying Common Stock (69,794) — exercise price 1.60
Disposed (D)69,7941.60
111,670.4

Derived: shares × price per share. Exact value 111670.40.

0Direct (D) No
F1
  • F1 The Options vest and are exercisable over a twelve month period, with vesting to occur on January 31, 2017, April 30, 2017, July 31, 2017 and October 31, 2017, respectively.
Open filing 0001628280-26-066091 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,176 filings read.

Showing 1–27 of 27

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BATTERY MANAGEMENT CORP. 2,421,673 SH12,108,365 dollarsUnchanged Prior quarter: 2,421,673Open filing 0001548594-26-000015 Filed 2026-11-16 Dispute this row
NEA Management Company, LLC 1,713,720 SH8,568,600 dollarsUnchanged Prior quarter: 1,713,720Open filing 0001072613-26-000901 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 301,353 SH1,506,765 dollarsUnchanged Prior quarter: 301,353Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
TOCQUEVILLE ASSET MANAGEMENT L.P. 295,658 SH1,478,290 dollarsUnchanged Prior quarter: 295,658Open filing 0000919574-26-007782 Filed 2026-11-13 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager212,668 SH1,063,340 dollarsLower by 1,390 Prior quarter: 214,058Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager195,600 SH978,000 dollarsLower by 39,800 Prior quarter: 235,400Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager129,639 SH648,195 dollarsLower by 9,400 Prior quarter: 139,039Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
BlackRock, Inc. Partly reported under another manager128,539 SH642,695 dollarsLower by 1,309 Prior quarter: 129,848Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
Mink Brook Asset Management LLC 111,338 SH556,690 dollarsUnchanged Prior quarter: 111,338Open filing 0001437749-26-036940 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager76,300 SH381,590 dollarsUnchanged Prior quarter: 76,300Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
HighTower Advisors, LLC 41,901 SH209,505 dollarsUnchanged Prior quarter: 41,901Open filing 0001085146-26-000933 Filed 2026-11-10 Dispute this row
VANGUARD FIDUCIARY TRUST CO 40,677 SH203,385 dollarsHigher by 7,438 Prior quarter: 33,239Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager27,886 SH139,430 dollarsLower by 24 Prior quarter: 27,910Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager26,203 SH131,015 dollarsUnchanged Prior quarter: 26,203Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager21,614 SH108,070 dollarsUnchanged Prior quarter: 21,614Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager20,523 SH102 dollarsUnchanged Prior quarter: 20,523Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row
JANE STREET GROUP, LLC Option: Put Partly reported under another manager19,200 SH96,000 dollarsNot in the prior quarter’s filings read Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
Mesirow Financial Investment Management, Inc. 15,800 SH79,000 dollarsUnchanged Prior quarter: 15,800Open filing 0001469475-26-000005 Filed 2026-11-05 Dispute this row
MERCER GLOBAL ADVISORS INC /ADV Partly reported under another manager12,775 SH63,875 dollarsUnchanged Prior quarter: 12,775Open filing 0000853758-26-000020 Filed 2026-11-16 Dispute this row
Cambridge Investment Research Advisors, Inc. 12,252 SH61 dollarsLower by 12,252 Prior quarter: 24,504Open filing 0001419186-26-000008 Filed 2026-11-02 Dispute this row
Vanguard Global Advisers, LLC 2,093 SH10,465 dollarsUnchanged Prior quarter: 2,093Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row
Nuveen, LLC Partly reported under another manager101 SH484 dollarsNot in the prior quarter’s filings read Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
Capital Advisors, Ltd. LLC 48 SH0 dollarsUnchanged Prior quarter: 48Open filing 0001597878-26-000005 Filed 2026-10-27 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager11 SH54 dollarsUnchanged Prior quarter: 11Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
Cassaday Co Wealth Management LLC 10 SH50 dollarsUnchanged Prior quarter: 10Open filing 0001963612-26-000006 Filed 2026-10-27 Dispute this row
SBI Securities Co., Ltd. 4 SH20 dollarsUnchanged Prior quarter: 4Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row
BARCLAYS PLC Partly reported under another manager3 SH15 dollarsLower by 10 Prior quarter: 13Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • CITADEL ADVISORS LLC 18,295 SH
  • ESSEX INVESTMENT MANAGEMENT CO LLC 18,221 SH
  • FMR LLC 1 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

No Schedule 13D or 13G naming this issuer is in the store; this is not a statement that none were filed.

What was read

2,686,506 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015103,592
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,124

Filings made before the SEC required XML are listed, not extracted.

Back to CHAMPIONS ONCOLOGY, INC.